The beneficial effects of morroniside on the inflammatory response and lipid metabolism in the liver of db/db mice

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 10, 2009, Pages 1734-1740

  Park, Chan Hum ^a   Yamabe, Noriko ^a   Noh, Jeong Sook ^a   Kang, Ki Sung ^a   Tanaka, Takashi ^b   Yokozawa, Takako ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

C57BLKS J db db mouse; Dyslipidemia; Inflammation; Morroniside; Oxidative stress; Type 2 diabetes

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLESTEROL; CYCLOOXYGENASE 2; GLUCOSE; GLUTATHIONE; INDUCIBLE NITRIC OXIDE SYNTHASE; IRIDOID; LIPID; MORRONISIDE; REACTIVE OXYGEN METABOLITE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRANSCRIPTION FACTOR RELA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; DYSLIPIDEMIA; FLUID INTAKE; FOOD INTAKE; HEPATITIS; HYPERGLYCEMIA; LIPID METABOLISM; LIPOGENESIS; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL;

ALANINE TRANSAMINASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTILIPEMIC AGENTS; ANTIOXIDANTS; CORNUS; DIABETES MELLITUS, EXPERIMENTAL; DOWN-REGULATION; FRUIT; GENE EXPRESSION; GLUCOSE; GLUTATHIONE; GLYCOSIDES; INFLAMMATION MEDIATORS; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHYTOTHERAPY; PLANT EXTRACTS; PPAR ALPHA; REACTIVE OXYGEN SPECIES; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; THIOBARBITURATES; TRIGLYCERIDES;

EID: 70349952314     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.1734     Document Type: Article

References (46)

1. Zimmet P., Alberti K. G., Shaw J., Nature (London), 13, 782-787 (2001).
2. Hancock J. T., Biochem. Soc. Trans., 29, 345-350 (2001).
3. Liu P. K., Arora T., J. Neurosci. Res., 15, 713-720 (2002).
4. Napoli C., de Nigris F., Palinski W., J. Cell. Biochem., 82, 674-682 (2001).
5. Barnes P. J., Int. J. Biochem. Cell Biol., 29, 867-870 (1997).
6. Yamamoto Y., Gaynor R. B., Curr. Mol. Med., 1, 287-296 (2001).
7. Zhang G. L., Wang Y. H., Teng H. L., Lin Z. B., World J. Gastroenterol., 7, 331-334 (2001).
8. Matsusue K., Gavrilova O., Lambert G., Brewer H. B. Jr., Ward J. M., Inoue Y., LeRoith D., Gonzalez F. J., Mol. Endocrinol., 18, 2751-2764 (2004).
9. Hancock J. T., Biochem. Soc. Trans., 29, 345-350 (2001).
10. Liu P. K., Arora T., J. Neurosci. Res., 15, 713-720 (2002).
11. Koch A., König B., Spielmann J., Leitner A., Stangl G. I., Eder K., J. Nutr., 137, 2018-2023 (2007).
12. Jump D. B., Botolin D., Wang Y., Xu J., Christian B., Demeure O., J. Nutr., 135, 2503-2506 (2005).
13. Brown M. S., Goldstein J. L., Cell, 89, 331-340 (1997).
14. Yamabe N., Kang K. S., Goto E., Tanaka T., Yokozawa T., Biol. Pharm. Bull., 30, 520-526 (2007).
15. Lena S., Victor A. A., Cambridge, 2002, 574 (2002).
16. Wang W., Huang W., Li L., Ai H., Sun F., Liu C., An Y., Cell. Mol. Neurobiol., 28, 293-305 (2008).
17. Yokozawa T., Yamabe N., Kim H. Y., Kang K. S., Hur J. M., Park C. H., Tanaka T., Biol. Pharm. Bull., 31, 1422-1428 (2008).
18. Yamabe N., Kang K. S., Matsuo Y., Tanaka T., Yokozawa T., Biol. Pharm. Bull., 30, 1289-1296 (2007).
19. Momose T., Yano Y., Ohashi K., Chem. Pharm. Bull., 11, 968-972 (1963).
20. Folch J., Lees M., Sloane Stanley G. H., J. Biol. Chem., 226, 497-509 (1957).
21. Ali S. F., LeBel C. P., Bondy S. C., Neurotoxicology, 13, 637-648 (1992).
22. Mihara M., Uchiyama M., Anal. Biochem., 86, 271-278 (1978).
23. Hissin P. J., Hilf R. A., Anal. Biochem., 74, 214-226 (1976).
24. Itzhaki R. F., Gill D. M. A., Anal. Biochem., 9, 401-410 (1964).
25. Yin M., Lou F., Cao Q., Han J., Ji H., China patent, CN 1839869 (2006).
26. Yamabe N., Kang K. S., Park C. H., Tanaka T., Yokozawa T., Biol. Pharm. Bull., 32, 657-664 (2009).
27. DeFronzo R. A., Bonadonna R. C., Ferannini E., Diabetes Care, 15, 318-368 (1992).
28. Hummel K. P., Dickie M. W., Coleman D. L., Diabetes, 153, 1127-1128 (1966).
29. Park C. W., Kim H. W., Ko S. H., Lim J. H., Ryu G. R., Chung H. W., Han S. W., Shin S. J., Bang B. K., Breyer M. D., Chang Y. S., J. Am. Soc. Nephrol., 18, 1227-1238 (2007).
30. Lee Y. A, Cho E. J., Yokozawa T., J. Agric. Food Chem., 10, 7781-7789 (2008).
31. Giardino I., Edelstein D., Brownlee M., J. Clin. Invest., 97, 1422-1428 (1996).
32. Brownlee M., Nature (London), 414, 813-820 (2001).
33. Nishikawa T., Edelstein D., Du X. L., Yamagishi S., Matsumura T., Kaneda Y., Yorek M. A., Beebe D., Oates P. J., Hammes H. P., Giardino I., Brownlee M., Nature (London), 404, 787-790 (2000).
34. Robertson R. P., J. Biol. Chem., 279, 42351-42354 (2004).
35. Bours V., Bonizzi G., Bentires-Alj M., Bureau F., Piette J., Lekeux P., Merville M., Toxicology, 153, 27-38 (2000).
36. Lawrence T., Gilroy D. W., Colville-Nash P. R., Willoughby D. A., Nat. Med., 7, 1291-1297 (2001).
37. Barnes P. J., Karin M., N. Engl. J. Med., 336, 1066-1071 (1997).
38. Yamamoto Y., Gaynor R. B., J. Clin. Invest., 107, 135-142 (2001).
39. Zhang Z., Liong E. C., Lau T. Y., Leung K. M., Fung P. C., Tipoe G. L., Int. J. Oncol., 16, 887-892 (2000).
40. Zhang G., Ghosh S., J. Clin. Invest., 107, 13-19 (2001).
41. Ruderman N. B., Saha A. K., Vavvas D., Witters L. A., Am. J. Physiol., 276, E1-E18 (1999).
42. Ginsberg H. N., J. Clin. Endocrinol. Metab., 91, 383-392 (2006).
43. Abrass C. K., Am. J. Nephrol., 24, 46-53 (2004).
44. Crook E. D., Thallapureddy A., Migdal S., Flack J. M., Greene E. L., Salahudeen A., Tucker J. K., Taylor H. A. Jr., Am. J. Med. Sci., 325, 340-348 (2003).
45. Nakatani T., Kim H. J., Kaburagi Y., Yasuda K., Ezaki O., J. Lipid Res., 44, 369-379 (2003).
46. Shimomura I., Matsuda M., Hammer R. E., Bashmakov Y., Brown M. S., Goldstein J. L., Mol. Cell, 6, 77-86 (2000).